NCT06961331
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic HER2+ Advanced Breast Cancer, +4 more
- Locations
-
- Pfizer New York, United States
Clinical trial condition
Metastatic HER2+ Advanced Breast Cancer
Explore clinical trials studying Metastatic HER2+ Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Metastatic HER2+ Advanced Breast Cancer trial results
Active, Not Recruiting
Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)
NCT05382364
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +15 more
- Locations
-
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- Hunan Cancer Hospital Changsha, Hunan, China
- Jilin Cancer Hospital Changchun, Jilin, China
- Fudan University Shanghai Cancer Center Shanghai, China